Buyco, Avelino Iii C.
HRN: 26-87-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
COTRIMOXAZOLE 960MG (TAB)
03/28/2025
04/17/2025
PO
960 Tab
TID
Immunocompromised
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes